NO901237L - 1h,3h-(1,2-c)-pyrrolo-7-tiazolkarboksamid. - Google Patents

1h,3h-(1,2-c)-pyrrolo-7-tiazolkarboksamid.

Info

Publication number
NO901237L
NO901237L NO90901237A NO901237A NO901237L NO 901237 L NO901237 L NO 901237L NO 90901237 A NO90901237 A NO 90901237A NO 901237 A NO901237 A NO 901237A NO 901237 L NO901237 L NO 901237L
Authority
NO
Norway
Prior art keywords
phenyl
alkyl
phenylalkyl
pyridyl
hydroxyalkyl
Prior art date
Application number
NO90901237A
Other languages
English (en)
Other versions
NO172392C (no
NO901237D0 (no
NO172392B (no
Inventor
Claude James
Daniel Lave
Francoise Soler
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO901237D0 publication Critical patent/NO901237D0/no
Publication of NO901237L publication Critical patent/NO901237L/no
Publication of NO172392B publication Critical patent/NO172392B/no
Publication of NO172392C publication Critical patent/NO172392C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO901237A 1989-03-17 1990-03-16 Analogifremgangsmaate for fremstilling av 1h,3h-(1,2-c)-pyrrolo-7-tiazolkarboksamider NO172392C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903510A FR2644456B1 (fr) 1989-03-17 1989-03-17 Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (4)

Publication Number Publication Date
NO901237D0 NO901237D0 (no) 1990-03-16
NO901237L true NO901237L (no) 1990-09-18
NO172392B NO172392B (no) 1993-04-05
NO172392C NO172392C (no) 1993-07-14

Family

ID=9379793

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901237A NO172392C (no) 1989-03-17 1990-03-16 Analogifremgangsmaate for fremstilling av 1h,3h-(1,2-c)-pyrrolo-7-tiazolkarboksamider

Country Status (24)

Country Link
US (1) US5086051A (no)
EP (1) EP0388309B1 (no)
JP (1) JPH02289586A (no)
KR (1) KR900014408A (no)
AT (1) ATE102210T1 (no)
BG (1) BG51159A3 (no)
CA (1) CA2012343A1 (no)
CS (2) CS438990A3 (no)
DD (1) DD297822A5 (no)
DE (1) DE69006872T2 (no)
DK (1) DK0388309T3 (no)
ES (1) ES2062432T3 (no)
FI (1) FI92069C (no)
FR (1) FR2644456B1 (no)
IE (1) IE63313B1 (no)
IL (1) IL93760A (no)
MA (1) MA21771A1 (no)
MX (1) MX26542A (no)
NO (1) NO172392C (no)
NZ (1) NZ232960A (no)
PL (1) PL284321A1 (no)
PT (1) PT93485B (no)
TN (1) TNSN90030A1 (no)
ZA (1) ZA902033B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW214545B (no) * 1992-02-17 1993-10-11 Ciba Geigy Ag
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
CA2140034A1 (en) 1992-07-13 1994-01-20 Xiong Cai 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
TW266206B (no) * 1993-04-28 1995-12-21 Takeda Pharm Industry Co Ltd
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5891895A (en) * 1996-04-15 1999-04-06 Takeda Chemical Industries, Ltd. Hydroxypyridine derivatives their production and use
JP5169216B2 (ja) * 2005-08-19 2013-03-27 独立行政法人産業技術総合研究所 色可逆変化表示装置用電極体及びその製造方法、並びに色可逆変化表示装置及び色可逆変化調光装置
WO2009125434A2 (en) * 2008-04-07 2009-10-15 Cadila Healthcare Limited Oxime derivatives
WO2014192023A1 (en) * 2013-05-22 2014-12-04 Cadila Healthcare Limited Novel compounds suitable for the treatment of dyslipidemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541280B1 (fr) * 1983-01-13 1985-06-21 Rhone Poulenc Sante Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent
FR2601016B1 (fr) * 1986-07-04 1988-10-07 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601015B1 (fr) * 1986-07-04 1988-08-05 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
PT93485B (pt) 1996-02-29
FI92069B (fi) 1994-06-15
IE900984L (en) 1990-09-17
FR2644456B1 (fr) 1991-07-05
CS125290A3 (en) 1992-03-18
NO172392C (no) 1993-07-14
ES2062432T3 (es) 1994-12-16
PT93485A (pt) 1990-11-07
FR2644456A1 (fr) 1990-09-21
CS438990A3 (en) 1992-03-18
MA21771A1 (fr) 1990-10-01
DE69006872T2 (de) 1994-06-30
FI92069C (fi) 1994-09-26
BG51159A3 (en) 1993-02-15
PL284321A1 (en) 1991-07-29
DK0388309T3 (da) 1994-04-11
ATE102210T1 (de) 1994-03-15
CS276785B6 (en) 1992-08-12
JPH02289586A (ja) 1990-11-29
IL93760A (en) 1994-08-26
IE63313B1 (en) 1995-04-05
DE69006872D1 (de) 1994-04-07
US5086051A (en) 1992-02-04
KR900014408A (ko) 1990-10-23
CA2012343A1 (fr) 1990-09-17
DD297822A5 (de) 1992-01-23
TNSN90030A1 (fr) 1991-03-05
EP0388309A2 (fr) 1990-09-19
FI901325A0 (fi) 1990-03-16
ZA902033B (en) 1990-12-28
NO901237D0 (no) 1990-03-16
NZ232960A (en) 1991-02-26
MX26542A (es) 1993-09-01
NO172392B (no) 1993-04-05
EP0388309A3 (fr) 1991-07-24
IL93760A0 (en) 1990-12-23
EP0388309B1 (fr) 1994-03-02

Similar Documents

Publication Publication Date Title
NO901237D0 (no) 1h,3h-(1,2-c)-pyrrolo-7-tiazolkarboksamid.
NL180206C (nl) Verbinding en geneesmiddel met analgetische werking.
PT807633E (pt) Novas pirimidin-4-onas substituidas em 2,3, e fundidas com heteroarilo em (5,6)
ATE35137T1 (de) Thieno(2,3-d)pyrimidin-derivate und deren salze.
ES8700856A1 (es) Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina
FR2653017A1 (fr) Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
IL76175A (en) N-substituted tricyclic oxindole carboxamides and pharmaceutical compositions containing them
BR8400549A (pt) Derivados e sais inertes de hidroxido de aminopiridinios e processos de preparacao;e composicao farmaceutica
ATE197706T1 (de) Anellierte dihydropyridine und deren verwendung für die herstellung von pharmazeutischen zubereitungen
FR2570701B1 (fr) Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
ES8601210A1 (es) Procedimiento para la preparacion de nuevos derivados de sinergistinas
FR2473522B1 (no)
GR3007918T3 (no)
DE3465306D1 (en) Disubstituted piperidines, processes for their preparation and pharmaceutical compositions containing them
DK159847C (da) Salte af 5-cyanopyridin-2-diazohydroxid
FR2672593B1 (fr) Nouveaux composes utiles pour la resolution de la dl-n-acetyle ou la dl-n-haloacetyl-hydroxyphenylglycine.
ES2036594T3 (es) Piperidinas, o azepinas substituidas, su preparacion y su aplicacion en terapeutica.